Kits Eyecare (KITS) Stock Forecast & Price Target

Compare

98 Followers

See the Price Targets and Ratings of:

All Analysts

Top Analysts

Premium

KITS Analyst Ratings

Strong Buy

6 Buy

0 Hold

0 Sell

Based on 6 analysts giving stock ratings to

Kits

Eyecare

in the past 3 months

TipRanks enables you to focus on the analyst rating consensus of all analysts or only the top performers in the past 3 months

KITS Stock 12 Month Forecast

Average Price Target

C$24.58

▲(74.57% Upside)

Based on 6 Wall Street analysts offering 12 month price targets for Kits Eyecare in the last 3 months. The average price target is C$24.58 with a high forecast of C$27.00 and a low forecast of C$21.50. The average price target represents a 74.57% change from the last price of C$14.08.

{"navigator":{"disabled":true},"exporting":{"enabled":false},"title":{"text":null},"chart":{"height":200,"style":{"fontFamily":"Roboto Flex, -apple-system, BlinkMacSystemFont, Segoe UI, Roboto, Helvetica, Arial, sans-serif, Apple Color Emoji, Segoe UI Emoji, Segoe UI Symbol","fontWeight":"400","color":"#5d5d5e"},"spacingTop":30,"spacingRight":60,"events":null},"yAxis":{"labels":{"style":{"color":"inherit"},"distance":6,"x":-6,"y":-6,"zIndex":1,"map_label_formatter":{"7":"C$7","28":"C$28","12.25":"C$12.25","17.5":"C$17.5","22.75":"C$22.8"}},"plotLines":[{"color":"rgba(0,0,0,0)","value":27,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":-10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-bottom flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#199ca5\">High </span>\n\n  <span style=\"color:#199ca5\">C$27.00</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":24.58,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":0,"text":"<div  class=\"positionrelative hoverZ3 triangleleft flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#828080\">Average </span>\n\n  <span style=\"color:#828080\">C$24.58</span>\n  </div></div>","useHTML":true}},{"color":"rgba(0,0,0,0)","value":21.5,"label":{"className":" overflowvisible_force","align":"right","x":60,"y":10,"text":"<div  class=\"positionrelative hoverZ3 triangleleft-top flexccc bgwhite shadowhard-3 border1 borderColorwhite-8 colorwhite-8 px2 lineHeight3 fontWeightsemibold fontSize10 radiismall h_pxsmall35\"> <div class=\"w_pxsmall60 flexccc\">\n  <span style=\"color:#912767\">Low </span>\n\n  <span style=\"color:#912767\">C$21.50</span>\n  </div></div>","useHTML":true}}],"tickPositions":[7,12.25,17.5,22.75,28],"lineColor":"#dddddd","gridLineWidth":1,"gridLineColor":"#dddddd","lineWidth":1,"title":{"text":""}},"plotOptions":{"series":{"states":{"inactive":{"opacity":1}}},"line":{"animation":{"duration":0},"dataLabels":{"allowOverlap":true},"borderWidth":1,"marker":{"enabled":true,"fillColor":"#FFFFFF","radius":3,"lineWidth":2,"symbol":"circle","lineColor":"#828080"}}},"xAxis":{"labels":{"style":{"color":"inherit"},"rotation":0,"map_label_formatter":{"3":"Jun<br/>2025","6":"Sep<br/>2025","9":"Dec<br/>2025","12":"Mar<br/>2026","25":"Mar<br/>2027"}},"tickPositions":[3,6,9,12,25],"plotLines":[{"color":"#dddddd","width":1,"value":12},{"color":"#dddddd","width":1,"value":12}],"lineWidth":0,"gridLineWidth":1,"gridLineColor":"#dddddd","tickLength":0},"legend":{"symbolRadius":0,"symbolPadding":4,"symbolHeight":14,"borderWidth":0,"symbolWidth":14,"align":"left","verticalAlign":"bottom","enabled":false},"tooltip":{"backgroundColor":"rgba(0,0,0,0)","useHTML":true,"borderWidth":0,"borderColor":"rgba(0,0,0,0)","padding":0,"shadow":null,"headerFormat":"","footerFormat":"","pointFormat":"<div class=\"flexccc lineHeight2 bgwhite shadow2 px3 py3 radiismall fonth10_semibold\">\n                <span class=\"colorgray-3 mb4\">{point.date:%b %d ,%Y}</span>\n                <span>Analyst Consensus</span>\n                {point.info}\n          </div>\n           </div>"},"credits":{"enabled":false},"accessibility":{"description":""},"responsive":{"rules":[{"chartOptions":{"chart":{"spacing":[0,0,0,0],"margin":[30,60,40,5]},"xAxis":{"tickPositions":[3,12,25.25]},"yAxis":{"labels":{"enabled":false}},"title":{"text":null},"subtitle":{"text":null}},"condition":{"maxWidth":500}}]},"series":[{"lineWidth":2,"dashStyle":"ShortDash","name":"High","type":"line","color":"#199ca5","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.52,18.24923076923077,18.978461538461538,19.70769230769231,20.436923076923076,21.166153846153847,21.895384615384614,22.624615384615385,23.353846153846153,24.083076923076923,24.81230769230769,25.54153846153846,26.270769230769233,{"y":27,"marker":{"fillColor":"#199ca5","lineColor":"#199ca5","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Average","type":"line","color":"#828080","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.52,18.063076923076924,18.606153846153845,19.14923076923077,19.692307692307693,20.235384615384614,20.77846153846154,21.32153846153846,21.864615384615384,22.407692307692308,22.95076923076923,23.493846153846153,24.036923076923074,{"y":24.58,"marker":{"fillColor":"#828080","lineColor":"#828080","enabled":true,"symbol":"circle"}}]},{"lineWidth":2,"dashStyle":"ShortDash","name":"Low","type":"line","color":"#912767","enableMouseTracking":false,"marker":{"enabled":false},"data":[null,null,null,null,null,null,null,null,null,null,null,null,17.52,17.826153846153847,18.13230769230769,18.43846153846154,18.744615384615383,19.05076923076923,19.356923076923078,19.663076923076922,19.96923076923077,20.275384615384617,20.58153846153846,20.88769230769231,21.193846153846152,{"y":21.5,"marker":{"fillColor":"#912767","lineColor":"#912767","enabled":true,"symbol":"circle"}}]},{"type":"line","data":[{"y":8.43,"date":1735689600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 9,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":8.84,"date":1740787200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 19,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":11.14,"date":1746057600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 1, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.39,"date":1748736000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 18,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":15.21,"date":1751328000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 10,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 0, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.72,"date":1754006400000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 4, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.33,"date":1756684800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 15,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":16.24,"date":1759276800000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 13,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 19, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.2,"date":1761955200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 7,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 30, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":14.95,"date":1764547200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 20,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 18, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":18.33,"date":1767225600000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 93,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 17, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":20.94,"date":1769904000000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 111,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 2, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"lineColor":"#199ca5","enabled":true,"symbol":"circle"}},{"y":17.52,"date":1772323200000,"info":" <span style=\"color:#199ca5\" class=\"mb3 mt2 fonth8_semibold\"> Strong Buy</span>\n            <div class=\"flexrcb px3 displayflex fonth9_semibold\"><span  style=\"color:#199ca5\">Buy 102,\t&nbsp; </span>\n              <span  style=\"color:#828080\">Hold 6, \t&nbsp;</span>\n              <span  style=\"color:#912767\">Sell 0</span>\n      ","marker":{"fillColor":"black","lineColor":"black","enabled":true,"symbol":"circle"}},null,null,null,null,null,null,null,null,null,null,null,null],"color":"#0666a7"}]}

Highest Price TargetC$27.00

Average Price TargetC$24.58

Lowest Price TargetC$21.50

The highest, average, and lowest price target of all analysts. Click on ‘Top Analysts’ to focus on the best performers.

Detailed List of Analyst Forecasts

Martin Landry

Stifel Nicolaus

C$24

Buy

70.45%

Upside

Reiterated

03/05/26

Stifel Nicolaus Sticks to Its Buy Rating for Kits Eyecare (KITS)

Luke Hannan

Canaccord Genuity

C$23

Buy

63.35%

Upside

Reiterated

03/05/26

Gianluca Tucci

Haywood

C$27

Buy

91.76%

Upside

Reiterated

03/05/26

Is KITS Eyecare still a buy?Tucci said organic growth remains strong at more than 20%, while the glasses category grew 33% year-over-year, reflecting the advantages of the companys vertically integrated platform.

Frederic Tremblay

Desjardins

C$23→C$25

Buy

77.56%

Upside

Reiterated

03/05/26

Kits Eyecare price target raised to C$25 from C$23 at DesjardinsKits Eyecare price target raised to C$25 from C$23 at Desjardins

Matt Koranda

Roth MKM

C$25→C$27

Buy

91.76%

Upside

Reiterated

03/05/26

Kits Eyecare (KITS) Gets a Buy from Roth MKM

Kyle McPhee

ATB Cormark Capital Markets

C$21.5

Buy

52.70%

Upside

Reiterated

01/05/26

Kits Eyecare downgraded to Speculative Buy from Buy at CormarkKits Eyecare downgraded to Speculative Buy from Buy at Cormark

Analyst Type

Any

Human Analysts

Ranks

Any

Analyst Rating

Any

Upside/ Downside

Any

Action

Any

Martin Landry

Stifel Nicolaus

C$24

Buy

70.45%

Upside

Reiterated

03/05/26

Stifel Nicolaus Sticks to Its Buy Rating for Kits Eyecare (KITS)

Luke Hannan

Canaccord Genuity

C$23

Buy

63.35%

Upside

Reiterated

03/05/26

Gianluca Tucci

Haywood

C$27

Buy

91.76%

Upside

Reiterated

03/05/26

Frederic Tremblay

Desjardins

C$23→C$25

Buy

77.56%

Upside

Reiterated

03/05/26

Kits Eyecare price target raised to C$25 from C$23 at DesjardinsKits Eyecare price target raised to C$25 from C$23 at Desjardins

Matt Koranda

Roth MKM

C$25→C$27

Buy

91.76%

Upside

Reiterated

03/05/26

Kits Eyecare (KITS) Gets a Buy from Roth MKM

Kyle McPhee

ATB Cormark Capital Markets

C$21.5

Buy

52.70%

Upside

Reiterated

01/05/26

Kits Eyecare downgraded to Speculative Buy from Buy at CormarkKits Eyecare downgraded to Speculative Buy from Buy at Cormark

Stocks with the Highest Top Analyst Consensus in the Consumer Cyclical Sector

xxx

Find stocks in the Consumer Cyclical sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Kits Eyecare

3 Months

xxx

Success Rate

9/14 ratings generated profit

Average Return

+18.35%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 3 Months would result in 64.29% of your transactions generating a profit, with an average return of +18.35% per trade.

1 Year

Luke HannanCanaccord Genuity

Success Rate

10/11 ratings generated profit

Average Return

+47.82%

reiterated a buy rating 18 days ago

Copying Luke Hannan's trades and holding each position for 1 Year would result in 90.91% of your transactions generating a profit, with an average return of +47.82% per trade.

2 Years

xxx

Success Rate

10/11 ratings generated profit

Average Return

+56.55%

reiterated a xxx

rating 18 days ago

Copying xxxxxxxxxxxxxxxxxx

trades and holding each position for 2 Years would result in 90.91% of your transactions generating a profit, with an average return of +56.55% per trade.

The Best Analyst Covering tool allows you to follow the analysts who have the best success rates and average returns on a specific stock. Only analysts that gave a Buy or Sell rating on the stock in the past 12 months are eligible for inclusion in this tool. Follow the analysts of your choice to receive real-time updates when they publish a new rating.

KITS Analyst Recommendation Trends

Rating

Nov 25

Dec 25

Jan 26

Feb 26

Mar 26

Strong Buy

Buy

111

Hold

Sell

Strong Sell

total

110

113

108

In the current month, KITS has received 102 Buy Ratings, 6 Hold Ratings, and 0 Sell Ratings. KITS average Analyst price target in the past 3 months is 24.58.

Each month's total comprises the sum of three months' worth of ratings.

KITS Financial Forecast

KITS Earnings Forecast

Next quarter’s earnings estimate for KITS is C$0.05 with a range of C$0.05 to C$0.05. The previous quarter’s EPS was C$0.03. KITS beat its EPS estimate ― of the time in the past 12 months, while its overall industry beat the EPS estimate 58.70% of the time in the same period. In the last calendar year KITS has Performed in-line its overall industry.

KITS Sales Forecast

Next quarter’s sales forecast for KITS is C$59.12M with a range of C$58.90M to C$59.70M. The previous quarter’s sales results were C$53.89M. KITS beat its sales estimates ― of the time in past 12 months, while its overall industry beat sales estimates 59.72% of the time in the same period. In the last calendar year KITS has Performed in-line its overall industry.

KITS Stock Forecast FAQ

What is TSE:KITS’s average 12-month price target, according to analysts?

Based on analyst ratings, Kits Eyecare’s 12-month average price target is 24.58.

What is TSE:KITS’s upside potential, based on the analysts’ average price target?

Kits Eyecare has 74.57% upside potential, based on the analysts’ average price target.

Can I see which stocks the top-ranking analysts are rating?

Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.

How can I follow the stock ratings of top Wall Street analysts?

Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.

Is TSE:KITS a Buy, Sell or Hold?

Kits Eyecare has a consensus rating of Strong Buy which is based on 6 buy ratings, 0 hold ratings and 0 sell ratings.

What is Kits Eyecare’s price target?

The average price target for Kits Eyecare is 24.58. This is based on 6 Wall Streets Analysts 12-month price targets, issued in the past 3 months.
The highest analyst price target is C$27.00 ,the lowest forecast is C$21.50. The average price target represents 74.57% Increase from the current price of C$14.08.

What do analysts say about Kits Eyecare?

Kits Eyecare’s analyst rating consensus is a Strong Buy. This is based on the ratings of 6 Wall Streets Analysts.

How can I buy shares of TSE:KITS?

Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.

Kits Eyecare (KITS) Stock Forecast & Price Target

KITS Analyst Ratings

KITS Stock 12 Month Forecast

Average Price Target

Detailed List of Analyst Forecasts​

Best Analysts Covering Kits Eyecare

KITS Analyst Recommendation Trends

KITS Financial Forecast

KITS Earnings Forecast

KITS Sales Forecast

KITS Stock Forecast FAQ

Detailed List of Analyst Forecasts